SM

Shyamala Mekala

Active Director Designated Partner DIN 10479960
DIN 10479960 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shyamala Mekala

Data last updated:

Shyamala Mekala is a Designated Partner at Basilwin Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10479960
Primary Designation Designated Partner
Industry Pharma
First Appointment 25 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Jan 20242024Active

Board colleagues of Shyamala Mekala

NameDINCompanyDesignation
Kalyani Chinthala10479959Basilwin Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Basilwin Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Shyamala Mekala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyamala Mekala

Shyamala Mekala currently holds 1 directorship: Basilwin Pharmaceuticals Llp (Designated Partner, since 25 Jan 2024).

Shyamala Mekala was first appointed on 25 Jan 2024 as Designated Partner at Basilwin Pharmaceuticals Llp.

The current boards of Shyamala Mekala's companies include Kalyani Chinthala (Basilwin Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available